NCT06545942 2026-04-17Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid TumorsMOMA TherapeuticsPhase 1 Active not recruiting220 enrolled
NCT03682289 2026-04-15Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid TumorsUniversity of California, San FranciscoPhase 2 Recruiting89 enrolled
NCT02419495 2025-06-04Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesM.D. Anderson Cancer CenterPhase 1 Terminated221 enrolled
NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled